SYNCHRONOUS TTF-1-POSITIVE TUMORS AND PITUITARY ADENOMAS. ARE WE SENDING INSUFFICIENT TUMOR TISSUE FOR PATHOLOGY?

被引：0

作者：

Rubino, Franco ^{[1
]}

Eichberg, Daniel ^{[2
]}

Shah, Ashish ^{[2
]}

Luther, Evan ^{[2
]}

Lu, Victor ^{[2
]}

Saad, Ali ^{[2
]}

Komotar, Ricardo ^{[2
]}

Ivan, Michael ^{[2
]}

机构：

[1] Univ Miami, Buenos Aires, DF, Argentina

[2] Univ Miami, Miami, FL USA

来源：

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

PATH-36

引用

页码：172 / 172

页数：1

共 4 条

[1] Welcoming the new WHO classification of pituitary tumors 2017: revolution in TTF-1-positive posterior pituitary tumors
Makoto Shibuya
Brain Tumor Pathology, 2018, 35 : 62 - 70
[2] Welcoming the new WHO classification of pituitary tumors 2017: revolution in TTF-1-positive posterior pituitary tumors
Shibuya, Makoto
BRAIN TUMOR PATHOLOGY, 2018, 35 (02) : 62 - 70
[3] Dabrafenib monotherapy for a recurrent BRAFV600E-mutated TTF-1-positive posterior pituitary tumor
Flavie Grenier-Chartrand
Sami Barrit
Marie Lucie Racu
Sylvie Luce
Julien Spitaels
Niloufar Sadeghi-Meibodi
Laetitia Lebrun
Isabelle Salmon
Florence Lefranc
Olivier De Witte
Acta Neurochirurgica, 2022, 164 : 737 - 742
[4] Dabrafenib monotherapy for a recurrent BRAFV600E-mutated TTF-1-positive posterior pituitary tumor
Grenier-Chartrand, Flavie
Barrit, Sami
Racu, Marie Lucie
Luce, Sylvie
Spitaels, Julien
Sadeghi-Meibodi, Niloufar
Lebrun, Laetitia
Salmon, Isabelle
Lefranc, Florence
De Witte, Olivier
ACTA NEUROCHIRURGICA, 2022, 164 (03) : 737 - 742